Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.
about
Highly sensitive real-time PCR for specific detection and quantification of Coxiella burnetiiFrom Q Fever to Coxiella burnetii Infection: a Paradigm Change.Antibiotic treatment of the tick vector Amblyomma americanum reduced reproductive fitness.Diversity and abundance of zoonotic pathogens and indicators in manures of feedlot cattle in Australia.Physicochemical and Nutritional Requirements for Axenic Replication Suggest Physiological Basis for Coxiella burnetii Niche Restriction.Correlation between ratio of serum doxycycline concentration to MIC and rapid decline of antibody levels during treatment of Q fever endocarditis.Polar localization of the Coxiella burnetii type IVB secretion system.Coxiella burnetii induces apoptosis during early stage infection via a caspase-independent pathway in human monocytic THP-1 cellsAntibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5' nuclease real-time PCR.Coxiella burnetii type IVB secretion system region I genes are expressed early during the infection of host cells.Development of a lipopolysaccharide-targeted peptide mimic vaccine against Q feverCharacterization of a lipopolysaccharide-targeted monoclonal antibody and its variable fragments as candidates for prophylaxis against the obligate intracellular bacterial pathogen Coxiella burnetii.Detection of A. phagocytophilum and E. chaffeensis in patient and mouse blood and ticks by a duplex real-time PCR assay.Isolation from animal tissue and genetic transformation of Coxiella burnetii are facilitated by an improved axenic growth medium.Growth of Coxiella burnetii in the Ixodes scapularis-derived IDE8 tick cell line.Cell-free propagation of Coxiella burnetii does not affect its relative virulenceClinical and pathologic changes in a guinea pig aerosol challenge model of acute Q feverDetection of Coxiella burnetii in complex matrices by using multiplex quantitative PCR during a major Q fever outbreak in The Netherlands.T cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice.Coxiella burnetii inhibits apoptosis in human THP-1 cells and monkey primary alveolar macrophagesAntimicrobial therapies for Q fever.Coxiella burnetii infection.Genome comparison analysis of molecular mechanisms of resistance to antibiotics in the Rickettsia genus.Inhibition of inflammasome activation by Coxiella burnetii type IV secretion system effector IcaA.Limited role for iron regulation in Coxiella burnetii pathogenesis.Comparison of PCR, immunofluorescence assay, and pathogen isolation for diagnosis of q fever in humans with spontaneous abortionsFormalin-inactivated Coxiella burnetii phase I vaccine-induced protection depends on B cells to produce protective IgM and IgG.Identification of Coxiella burnetii type IV secretion substrates required for intracellular replication and Coxiella-containing vacuole formationMurine Alveolar Macrophages Are Highly Susceptible to Replication of Coxiella burnetii Phase II In VitroCoxiella burnetii Avirulent Nine Mile Phase II Induces Caspase-1-Dependent Pyroptosis in Murine Peritoneal B1a B Cells.Coxiella burnetii isolates cause genogroup-specific virulence in mouse and guinea pig models of acute Q fever.Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infectionsTemporal analysis of Coxiella burnetii morphological differentiationEvaluation of antibiotic susceptibilities of Ehrlichia canis, Ehrlichia chaffeensis, and Anaplasma phagocytophilum by real-time PCR.In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.Quantitation of viable Coxiella burnetii in milk using an integrated cell culture-polymerase chain reaction (ICC-PCR) assay.Enhanced detection of Coxiella burnetii with a complementary locked primer-based real-time PCR method.Prevalence of Coxiella burnetii DNA in vaginal and uterine samples from healthy cats of north-central Colorado.Activity of telithromycin against thirteen new isolates of C. burnetii including three resistant to doxycycline.Comparative virulence of phase I and II Coxiella burnetii in immunodeficient mice.
P2860
Q25255435-49BBD3FF-53F5-4520-AFA1-38F74FF84A29Q30241105-C003543E-5459-4E77-888F-05E9138BAAB9Q33283513-2207F4C8-7AEB-45FB-BF76-2F9082DEABA0Q33676995-C11CF64F-99D6-4F9D-806C-F182C038F7A0Q33741451-AC9D71FA-C12B-489F-9AEE-4D45CCA2E9B0Q33883633-0FE5833E-C270-4BBD-8E6A-341E5B8091C2Q34012244-ED012978-200B-4238-8C21-552B18EDD0F3Q34150024-FD5554E2-7E02-4306-8726-703048CE28B6Q34228320-08F959A9-70CA-4647-AE47-1D8DAB010D83Q34283480-72AAEFD8-F4FF-4F31-AF1C-17995F64828BQ34440031-B477D18E-27F9-450A-9610-0B1C85B64958Q34596111-B74B0A59-7E4A-496F-9D4D-977918FF7E90Q34984761-5418DF61-5F81-4F60-81A4-20AD1D13C9CBQ35080771-4ED865F5-DE48-4A7A-9829-ABA9B5B72537Q35086324-07DC8704-5C1C-4AD6-9EDB-D724E384904AQ35203046-279BDADE-A22B-4377-8031-85A04C5DADBFQ35217556-AC1B0168-BC09-4A9F-8F60-92B34A436F19Q35271954-5CA866E8-2C51-4FBB-B45C-685679A01A83Q35913591-073D61FA-AA13-4073-8107-CC0E941213F1Q35947318-D4DA248B-176C-430A-B65B-21EB7120096DQ36169968-669C2A66-BED2-4913-93F8-5EAB8CE2155FQ36397829-72216DF5-F345-4092-A196-DC832AE7D4BFQ36397848-A4F3B38C-0980-40B2-8711-115AD581F26AQ36438042-A40D7F44-C5EE-48CE-AC02-8D6CD1521C1AQ36593950-91122870-8E71-4693-9A65-BD68BF8A2E6DQ36747435-A881E092-D517-4352-8825-261CD44C645DQ36911430-8DC11AED-462D-4298-8AC4-B47D893C698BQ37124987-E1EA9846-5BDE-45B4-A495-B27A1DD5E3CDQ37199818-BB7DA520-C939-42E6-80D3-47D6598AA84BQ37425047-CDB308F3-468B-4B91-AA09-A4CCC3254BE3Q37451089-3B38FD2F-DE3A-4652-97BA-4FC4A48ED34CQ37582812-57B04782-BA9F-4AA2-B977-FEA164CB0F41Q37583353-5903EDB4-2A2F-43DA-AFB5-C311500D894BQ37625411-B61B9A5D-2664-447F-A77E-56DFBE86B4B0Q39532963-CEB21376-F1FD-48C9-8805-91ACFC608CF7Q40148657-6E998065-8914-48B0-BE8E-F3DD1CCCF58DQ40329204-7FBCFB38-1961-4A1F-A805-2426DFE2BF44Q40460641-1BAFCB9C-8510-4C21-AF8D-FD97B806DE89Q40486065-66AA301C-8F95-483A-9573-37B52CC85848Q40486117-3A16583C-47CB-4CCA-8044-EA5AA2BE8305
P2860
Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.
@ast
Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.
@en
Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.
@nl
type
label
Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.
@ast
Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.
@en
Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.
@nl
prefLabel
Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.
@ast
Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.
@en
Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.
@nl
P2860
P1476
Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.
@en
P2093
James E Samuel
Robert E Brennan
P2860
P304
P356
10.1128/JCM.41.5.1869-1874.2003
P407
P577
2003-05-01T00:00:00Z